Mesoblast Balance Sheet Health
Financial Health criteria checks 4/6
Mesoblast has a total shareholder equity of $480.4M and total debt of $114.3M, which brings its debt-to-equity ratio to 23.8%. Its total assets and total liabilities are $669.2M and $188.8M respectively.
Key information
23.8%
Debt to equity ratio
US$114.35m
Debt
| Interest coverage ratio | n/a |
| Cash | US$62.96m |
| Equity | US$480.36m |
| Total liabilities | US$188.80m |
| Total assets | US$669.15m |
Financial Position Analysis
Short Term Liabilities: MSB's short term assets ($86.5M) exceed its short term liabilities ($73.2M).
Long Term Liabilities: MSB's short term assets ($86.5M) do not cover its long term liabilities ($115.6M).
Debt to Equity History and Analysis
Debt Level: MSB's net debt to equity ratio (10.7%) is considered satisfactory.
Reducing Debt: MSB's debt to equity ratio has increased from 16.9% to 23.8% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: MSB has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: MSB is forecast to have sufficient cash runway for 11 months based on free cash flow estimates, but has since raised additional capital.